NYSE:CMC
NYSE:CMCMetals and Mining

Is Commercial Metals (CMC) Still Fairly Priced After Its Strong Multi‑Year Share Price Run?

Commercial Metals (CMC) has quietly delivered a strong run lately, with the stock up about 19% over the past month and roughly 17% in the past 3 months, outpacing broader materials peers. See our latest analysis for Commercial Metals. Zooming out, Commercial Metals has posted a hefty year to date share price return of around 42 percent, and a five year total shareholder return north of 270 percent. This signals strong, sustained momentum as investors warm to its growth and earnings...
NYSE:QBTS
NYSE:QBTSSoftware

Does D-Wave Quantum’s Soaring 1,065.9% Gain Still Match Its Fundamentals in 2025?

If you are wondering whether D-Wave Quantum is still a speculative story stock or if the current price actually makes sense for long term investors, this article will walk through the numbers behind the hype. The stock has been extremely volatile, dropping 11.2% over the last week but still up 4.2% over the past month, 147.5% year to date and 165.5% over the last year, with a 1,065.9% gain over three years. Much of this wild ride has been driven by excitement around its annealing based...
NYSE:PR
NYSE:PROil and Gas

How Investors Are Reacting To Permian Resources (PR) Fresh Wave of Bullish Analyst Reaffirmations

In recent days, multiple Wall Street firms, including UBS and Mizuho, reiterated positive ratings on Permian Resources and adjusted their research views, signaling confidence in the company’s outlook within the oil and gas sector. This cluster of upbeat analyst opinions, paired with an overall "Outperform" consensus, underscores how professional sentiment can influence investor perception and trading activity. Now, we'll explore how this wave of reaffirmed positive analyst sentiment...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Assessing Fiserv After 2024 Share Price Slump and Digital Payments Expansion

Wondering if Fiserv is quietly turning into a value opportunity after a rough stretch, or if the market is still getting it wrong on price? Despite being down about 66.1% over the last year and 66.8% year to date, the stock has shown flickers of life recently, rising 2.6% in the last week and 9.0% over the past month to close around $68.33. Recent headlines have focused on Fiserv doubling down on its role in digital payments and banking infrastructure, including ongoing integrations of its...
NYSE:EMR
NYSE:EMRElectrical

Emerson Electric (EMR): Is the 12.7% Undervaluation Story Still Intact After Recent Share Price Strength?

Emerson Electric (EMR) has quietly outperformed many industrial peers this year, and with the stock hovering near 52 week highs, investors are asking whether current pricing still leaves enough upside on the table. See our latest analysis for Emerson Electric. The latest pullback sits against a solid backdrop, with a roughly 8 percent year to date share price return and an 82 percent five year total shareholder return suggesting momentum is cooling rather than breaking. If Emerson’s run has...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Do Supermicro’s New Liquid-Cooled Blackwell Racks Reshape Its AI Infrastructure Edge (SMCI)?

Earlier in December 2025, Super Micro Computer expanded its NVIDIA Blackwell architecture portfolio with new liquid-cooled HGX B300 systems, offering higher GPU density, improved power efficiency, and turnkey rack-scale AI “factory” deployments for hyperscale, enterprise, and government data centers. At the same time, Supermicro’s work with partners such as Cornelis and EdgeMode highlights how liquid cooling, high-speed networking, and sustainable infrastructure are becoming central to...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Wave Life Sciences (WVE) Is Down 19.2% After $350 Million Equity Raise On Obesity Data - What's Changed

Earlier in December 2025, Wave Life Sciences completed a roughly US$350.00 million follow-on equity offering, issuing 15,789,475 ordinary shares at US$19 each alongside 2,631,578 pre-funded warrants, after releasing positive interim Phase 1 INLIGHT data for obesity candidate WVE-007 showing improved body composition and a favorable safety profile. The combination of WVE-007’s early signs of durable, once- or twice-yearly obesity dosing potential and a sizable capital raise suggests Wave is...
NYSE:THC
NYSE:THCHealthcare

Is There Still Value in Tenet Healthcare After Its 57% 2025 Rally?

Wondering if Tenet Healthcare's huge run up has already priced in the upside, or if there is still value left on the table for new investors? The stock has eased back about 2.5% over the last week, but is still up 2.1% over 30 days and 57.2% year to date, building on a 48.5% gain over 1 year and more than tripling over 3 and 5 years. Recent headlines have focused on Tenet's continued strategic focus on its ambulatory surgery and specialty care network, along with ongoing portfolio...
NasdaqGS:TXRH
NasdaqGS:TXRHHospitality

Is It Too Late to Consider Texas Roadhouse After Its Recent Share Price Pullback?

Wondering if Texas Roadhouse at around $165 a share is still a bargain or if the easy gains are gone? This piece will walk through what the current price is really baking in. The stock is roughly flat in the very short term, up 0.5% over the last week and down 0.9% over the past month. That sits against a tougher backdrop of an 8.5% drop year to date and a 9.9% slide over the last year, after a huge 81.4% and 124.5% run over the past 3 and 5 years respectively. Investors have been reacting...
NYSE:NOC
NYSE:NOCAerospace & Defense

Is It Too Late To Consider Northrop Grumman After 21.5% Gains In 2025?

If you are wondering whether Northrop Grumman at around $568 a share is still a smart buy, or if the big gains are already behind it, you are not alone. That is exactly what this breakdown will tackle. The stock is up 3.3% over the last week, 1.9% over the past month, and 21.5% year to date, building on a 20.5% gain over the last year and 108.4% over five years. Recent headlines have focused on Northrop Grumman's expanding role in defense and space programs, including high profile contracts...
NYSE:ABBV
NYSE:ABBVBiotechs

Does AbbVie Still Offer Upside After Its Big Run And Recent Pullback?

If you are wondering whether AbbVie is still worth considering after its big run, or if its best days are behind it, this breakdown is for you if you care about what you are actually paying for the growth story. Despite a 25.0% gain year to date and a 34.2% rise over the last year, AbbVie has cooled off recently, slipping 0.4% over the past week and 4.1% over the past month after touching around $224.31. Recent headlines have focused on AbbVie's continued push to diversify beyond Humira with...
NYSE:KEX
NYSE:KEXShipping

Will Kirby’s (KEX) Q3 Revenue Beat on Marine and Power Demand Change Its Investment Narrative?

In its recently reported third-quarter results, Kirby posted revenues of US$871.2 million, a 4.8% year-on-year increase that exceeded analyst expectations by 2.3%, with management highlighting continued strength in coastal marine and power generation operations. This performance underlines Kirby’s ability to adapt to current industry conditions while converting demand in its core marine and power-focused businesses into tangible top-line growth. With Kirby surpassing revenue expectations on...
NYSE:ALB
NYSE:ALBChemicals

Is Albemarle’s 58.1% Rally in 2025 Justified by Its Lithium Growth Prospects?

Wondering if Albemarle is finally a smart way to play the lithium story without overpaying for hype? You are not alone; this stock is back on a lot of watchlists. After a rough few years, Albemarle has bounced with a 1.1% gain over the last week, 14.5% over the last month, 58.1% year to date, and 51.9% over the last year, even though the 3 year and 5 year returns are still negative at -39.5% and -4.7%. Much of this renewed interest links back to shifting expectations around long term lithium...
NYSE:AER
NYSE:AERTrade Distributors

Assessing AerCap (AER) Valuation After a Strong 3-Month and 1-Year Share Price Rally

AerCap Holdings (NYSE:AER) has quietly rewarded patient shareholders, with the stock climbing about 16% over the past 3 months and roughly 46% year to date, inviting a closer look at what is driving returns. See our latest analysis for AerCap Holdings. That mix of a 16.3% 3 month share price return and a powerful 54.9% 1 year total shareholder return suggests momentum is still building as investors reassess AerCap’s earnings power and capital returns. If AerCap’s run has you rethinking where...
NYSE:REXR
NYSE:REXRIndustrial REITs

Does Rexford Industrial Realty’s Recent Share Performance Offer a Long Term Opportunity in 2025?

If you are wondering whether Rexford Industrial Realty is quietly becoming a value opportunity or just fairly priced industrial real estate, you are in the right place. Rexford's share price now sits around $40.72, with returns of 2.7% over the last week, a modest 6.0% year to date, and 6.6% over the past year after a choppy 3 to 5 year stretch. Recently, the stock has been in focus as investors reassess demand for infill industrial properties in key coastal markets and the resilience of...
NYSE:RACE
NYSE:RACEAuto

Is Ferrari Still Worth Its Premium After The Recent 13.7% Share Price Slide?

If you are wondering whether Ferrari's premium share price still makes sense or if there is a hidden opportunity here, you are in the right place as we unpack what the market is really paying for this brand. After an exceptional multi year run, with the stock up 76.7% over 3 years and 68.2% over 5 years, recent returns have cooled, with the share price down 1.3% over 7 days, 11.2% over 30 days and 11.0% year to date, contributing to a 13.7% drop over the last year. That pullback comes as...
NYSE:MTDR
NYSE:MTDROil and Gas

Assessing Matador Resources (MTDR) Valuation After a Choppy Share Price Run in 2024

Matador Resources (MTDR) has had a choppy run lately, with the stock bouncing between near term gains and a weaker year to date trend. This has left investors debating whether this pullback is an opportunity or a warning. See our latest analysis for Matador Resources. Zooming out, the recent 1 day share price gain sits against a much weaker year to date share price return and a softer 1 year total shareholder return. This suggests momentum has been fading even as long term holders remain well...
NYSE:DVN
NYSE:DVNOil and Gas

Devon Energy (DVN) Valuation Check After Q3 Earnings Beat and Fresh Wall Street Upgrades

Devon Energy (DVN) just delivered a third quarter earnings beat that paired higher production with stronger free cash flow, and Wall Street quickly took notice, backing the stock with a wave of more constructive ratings. See our latest analysis for Devon Energy. The latest earnings surprise has helped Devon’s 1 day share price return of 5.3 percent stand out against a steadier backdrop. A 1 year total shareholder return of 22.1 percent and a 5 year total shareholder return above 200 percent...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp (NTAP) Valuation Check After Recent Share Price Pullback

NetApp (NTAP) shares have been drifting after a choppy few months, slipping over the past week but still modestly higher for the month. This sets up an interesting mismatch between recent volatility and longer term performance. See our latest analysis for NetApp. At around $110.95 per share, NetApp’s recent slide, including a weak 7 day share price return, looks more like a pause in what has been a solid multi year total shareholder return story. This suggests momentum is cooling rather than...
NasdaqGS:CAKE
NasdaqGS:CAKEHospitality

Cheesecake Factory (CAKE): Reassessing Valuation After a 13% One-Month Share Price Rebound

Cheesecake Factory (CAKE) has quietly outperformed the broader market over the past month, climbing about 13%, as investors reassess the chain’s pricing power, traffic trends, and improving profitability. See our latest analysis for Cheesecake Factory. That recent 1 month share price return of 13.33% comes after a choppier quarter. However, with the stock now at $50.26 and a 3 year total shareholder return of 74.47%, momentum still looks more constructive than not. If Cheesecake Factory’s...
NYSE:RBLX
NYSE:RBLXEntertainment

Has Roblox Run Too Far After Its 205.8% Three Year Surge?

Wondering if Roblox at around $85.91 is still worth chasing after its big run, or if the risk is finally catching up with the hype? In this article, we unpack what the current price really implies about future growth. The stock has pulled back about 9% over the last week and roughly 15.2% over the past month, even though it is still up around 46% year to date and 46.1% over the past year, and a huge 205.8% over three years. Recent moves have been driven by shifting sentiment around user...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Valuation Check as Q2 2026 Earnings, Cost Cuts and Freight Spin-Off Draw Investor Focus

FedEx (FDX) is back in the spotlight as investors gear up for its Q2 2026 earnings on December 18, with attention fixed on three things: earnings momentum, cost cuts, and the coming FedEx Freight spin off. See our latest analysis for FedEx. That backdrop of upbeat commentary and the coming Freight spin off has helped fuel a 25.1% 3 month share price return to $282.46, while the 3 year total shareholder return of 83.3% shows longer term momentum is still very much intact. If FedEx’s setup has...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Is Gilead Sciences Still Attractive After Its 2025 Surge and Oncology Pipeline Momentum

If you are wondering whether Gilead Sciences is still a smart consideration after its big run, or if you are late to the party, this breakdown will help you assess whether the current price makes sense or is quietly offering value. The stock is flat over the last week and down 2.2% over the past month, but it is still up 32.1% year to date and 156.3% over five years, which indicates that sentiment has shifted in a significant way. Recent headlines have focused on Gilead's expanding oncology...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

Is Keurig Dr Pepper a Hidden Opportunity After Recent Share Price Weakness?

Wondering if Keurig Dr Pepper is quietly turning into a value opportunity while the market looks elsewhere? This breakdown will help you decide whether the current price really makes sense. Despite trading at around $28.59, the stock is roughly flat to slightly negative over the last week at -1.6%, has climbed 5.4% over the last month, but is still down -10.0% year to date and -10.8% over the past year. This hints that sentiment may be in the middle of a slow reset. Recent headlines have...